The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.

from NYT > Health https://ift.tt/3bRljjG

Related Posts:

0 comments:

Post a Comment

Popular Posts